Innovative Medicines Initiative [email protected] aims to reshape clinical trial design, conduct and operations by developing and piloting standards, recommendations and tools to define and operationalize remote decentralized clinical trials (RDCTs). To date, this consortium of SMEs, private foundations, academia, and EFPIA members have analyzed over 46 remote studies to develop a list of best practices when building decentralized trials.
This webinar will present the latest results and updates from the IMI, as well as important considerations when developing decentralized strategies for clinical trials. As frontline solution providers and members of the IMI, MRN and eClinical Health will give insights into how to maximize the value of decentralized solutions.
Paul Bodfish, Vice President of Corporate Services, Medical Research Network
A biologist by education, Paul Bodfish has spent over 25 years in the clinical research sector in a variety of roles and is an expert in understanding and overcoming the challenges associated with the regulatory and practical elements of successfully running decentralized clinical trials. Paul is one of the original founders of Medical Research Network and, in his current role, is responsible for the ongoing development of MRN’s quality management system, which continues to evolve as the industry moves into more decentralized trial models. Paul is MRN’s representative on the IMI [email protected] consortium.Message Presenter
Bobby Davey, Director of Product Management, Chief Information Security Officer, eClinicalHealth
With over 20 years’ experience, Bobby has considerable expertise spanning research, development, product and relationship management. He has a proven track record of innovation, strategic technology direction and delivery spanning multi-national companies and fast-moving new businesses. He is accustomed to leading multiple cross-functional teams in an international business context. He brings to eClinicalHealth an in-depth knowledge of the clinical trials, medical imaging, healthcare informatics, bioinformatics, software engineering and high-performance computing sectors.Message Presenter
Who Should Attend?
This webinar will benefit those involved in clinical trials, with relevant job titles including:
- Chief Executive Officer
- Clinical Director
- Clinical Innovation
- Clinical Development Director
- Medical Director
- Operational Director
- Patient Engagement
- Patient Advocacy
- Patient Services
- Research Director
What You Will Learn
- When it is most appropriate to use decentralized solutions
- How to truly integrate decentralized solutions into your trial design
- How to maximize the value and benefit of decentralized solutions
At MRN we understand the complexities of today’s clinical trial environment and the burden this places on patients, clients and sites. Our services are designed to ease these burdens, from community research nurses through to investigator site professional support, accelerating patient recruitment and retention. We work to maximize the efficiency of clinical trials for drug developers, by improving the patient’s experience, no matter where their community is in the world. We continually work to improve our products and processes, constantly innovating based on industry-leading experience, so we can deliver the complex efficiently, by helping patients in their community.